28.10.2014 Views

What Is Evidence-Based Medicine?1 - Surgical Planning Laboratory

What Is Evidence-Based Medicine?1 - Surgical Planning Laboratory

What Is Evidence-Based Medicine?1 - Surgical Planning Laboratory

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Special Report<br />

Radiology Alliance for Health Services Research<br />

<strong>What</strong> <strong>Is</strong> <strong>Evidence</strong>-<strong>Based</strong> <strong>Medicine</strong>? 1<br />

Critical Thinking Skills Symposium<br />

Kelly H. Zou, PhD, Julia R. Fielding, MD, Silvia Ondategui-Parra, MD, MPH, MSc<br />

Rationale and Objectives. In this review article, we present the definition and useful concepts of evidence-based medicine<br />

(EBM). The principles of EBM are provided and major steps of practicing EBM are described.<br />

Materials and Methods. We emphasize the importance of the Cochrane Collaboration (see http://www.cochrane.org),<br />

which initiated the research and practice in this area. Because it can be difficult to systematically access and review individual<br />

research studies, it is often useful to focus on a critical overview of clinical trials by conducting a meta-analysis.<br />

Results. Useful literature and resources related to meta-analysis are provided.<br />

Conclusion. Statistical methods for evaluating radiologic diagnostic performances derived from meta-analysis are summarized,<br />

with a special focus on summary outcomes measures.<br />

Key Words. <strong>Evidence</strong>-based medicine; evidence-based radiology; meta-analysis; sensitivity; specificity; receiver operating<br />

characteristic curve.<br />

© AUR, 2004<br />

Acad Radiol 2004; 11:127–133<br />

1<br />

From the Radiology Management Group, Department of Radiology,<br />

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Department<br />

of Health Care Policy, Harvard Medical School, Boston, MA; Department<br />

of Radiology, University of North Carolina at Chapel Hill, Chapel<br />

Hill, NC; Department of Health Policy and Management, Harvard School of<br />

Publish Health, Boston, MA. Received July 14, 2003; revision requested<br />

August 28; received in revised form September 8; accepted September 9.<br />

Partially supported by a research grant R03HS13234-01 from the National<br />

Institutes of Health. Address correspondence to Kelly H. Zou e-mail:<br />

zou@bwh.harvard.edu<br />

© AUR, 2004<br />

doi:10.1016/S1076-6332(03)00650-0<br />

<strong>Evidence</strong>-based medicine (EBM), also called evidencebased<br />

health care, was developed because of the awareness<br />

of the limitations of traditional determinants. The<br />

principles of EBM offer a useful solution to clinical problems<br />

to acquire valid and current information for clinical<br />

and policy decisions (1). EBM is defined as the process<br />

of systematically finding, critically appraising, and using<br />

contemporary research published in the medical literature<br />

as a basis for making decisions regarding individual patient<br />

care and health care policy. It is also a habit that is<br />

recommended to all practicing radiologists so that they<br />

use the best logical thinking techniques to derive treatment<br />

plans (2–4).<br />

A comprehensive review of EBM applied to radiology<br />

was recently published (1). However, so far these developments<br />

have received limited applications in radiology.<br />

The link between EBM and evidence-based radiology is<br />

aimed at integration of evaluative sciences and technology<br />

assessment into clinical practice (2).<br />

There are several approaches for EBM. It is recognized<br />

that one of the best methods for reviewing a field of information<br />

and to systematically access individual research<br />

studies is to conduct a meta-analysis. It is important for<br />

radiologists to realize that EBM offers solutions that can<br />

be applied at many levels of professional involvement. A<br />

unique feature of EBM is that it can be used readily by<br />

practicing radiologists working at the effectiveness level:<br />

performance in their own departments under ordinary<br />

clinical practice (1).<br />

127


ZOU ET AL Academic Radiology, Vol 11, No 2, February 2004<br />

Table 1<br />

Trends in <strong>Evidence</strong>-based <strong>Medicine</strong> From 1995 to 2002 Using<br />

MEDLINE Search with Subject Heading Words “<strong>Evidence</strong>based<br />

<strong>Medicine</strong>”<br />

Year Number of Publications Relative Frequency (%)<br />

1995 20 0.2<br />

1996 215 2.0<br />

1997 678 6.2<br />

1998 1075 9.8<br />

1999 1611 14.7<br />

2000 1889 17.2<br />

2001 2573 23.4<br />

2002 2919 26.6<br />

Total 10980 100.0<br />

First, in this article, we will focus on how to integrate<br />

EBM techniques into daily clinical practice. We will then<br />

review the basic steps required to perform a meta-analysis.<br />

Finally, a summary and concluding remarks are provided.<br />

EVIDENCE-BASED MEDICINE IN RADIOLOGY<br />

RADIOLOGY<br />

The number of articles published on EBM has seen a<br />

dramatic increase. The trends of conducting EBM between<br />

1995 and 2002, based on a MEDLINE search using<br />

the subject heading “evidence-based medicine,” are<br />

provided (Table 1). The major work of evidence-based<br />

medicine is to draw conclusions from results collected<br />

from literature, and alternatively, from narrative reviews<br />

and data pooled from independent studies—often clinical<br />

trials. The main methodologic approach is to perform a<br />

systematic statistical analysis to extract, compare, and<br />

combine the reported results from these studies to derive<br />

quantifiable outcomes (2). Explicit criteria are necessary<br />

to render an objective assessment of the study’s value.<br />

Such criteria include inclusion and exclusion subject criteria<br />

with assessment of bias, reasonableness of the clinical<br />

intervention, appropriateness of the statistical evaluation,<br />

and overall credibility when compared with a practitioner’s<br />

medical knowledge.<br />

There are four major steps to the practice of evidencebased<br />

medicine (4), as described in the following sections.<br />

Step 1. Formulate the Clinical Question<br />

This first step is the single most important one, and<br />

requires careful thought. It is best to formulate the clinical<br />

question in the form of an exposure and patient outcome.<br />

For example, “Does the use of contrast-enhanced<br />

computed tomography (CT) scan of the chest (exposure/<br />

possible harm) as a primary test for dyspnea in a 68-yearold<br />

woman with a normal chest radiograph reduce her<br />

risk of dying of pulmonary embolus?” The more detail<br />

incorporated into the clinical question, the more specific<br />

is the relevant literature review. In this example, the patient’s<br />

age, symptoms, and chest radiograph findings are<br />

included. Thus, in the literature review, one could disregard<br />

articles describing young patients, asymptomatic patients,<br />

and those patients with abnormal chest radiographs.<br />

Step 2. Find the <strong>Evidence</strong><br />

Conventionally, radiologists may search for useful evidence<br />

for clinical practice without applying appropriate or<br />

scientific methods. For example, one may discuss a case<br />

with a colleague or mentor, retrieve individual research<br />

articles, and review quality and relevance-filtered publications.<br />

The limitation in such practice is that the expert<br />

opinion can be out of date and even incorrect, particularly<br />

when confronted with a very rare disease or unusual manifestation<br />

of a more common ailment. Alternatively, many<br />

radiologists keep paper or electronic files of individual<br />

research articles, usually divided by organ system. These<br />

files, when critically reviewed and kept up to date, may<br />

help understand the current status of imaging a particular<br />

disease. Unfortunately, the clinical information from these<br />

personal files typically does not represent that using a<br />

population-based approach, which is relevant to the individual<br />

case to be diagnosed or treated. Therefore, sophisticated<br />

and robust methods are needed for systematically<br />

combining evidence.<br />

Computer databases such as MEDLINE and PUBMED<br />

have shown to be invaluable in these cases. The Cochrane<br />

Collaboration, based in the United Kingdom, recommends<br />

performing meta-analyses rather than the ad hoc combination<br />

of information present in the literature. Founded by<br />

Dr. Archie Cochrane in 1972, the goal of the group is to<br />

determine, in well-designed studies, which therapies are<br />

effective and then to use health care resources to provide<br />

these therapies to the population in an equitable and presumably<br />

cost-effective manner. In this group, reviewers,<br />

consumers, translators, and hand searchers submit work to<br />

an editorial team assigned to a particular health care<br />

project. Using predetermined eligibility criteria, studies<br />

are selected to provide the largest dataset possible. A<br />

meta-analysis is then performed on these studies. The<br />

results of the analysis form the basis of a report that<br />

128


Academic Radiology, Vol 11, No 2, February 2004<br />

WHAT IS EVIDENCE-BASED MEDICINE?<br />

makes recommendations on the usefulness of a particular<br />

test or therapy. In the United States, for example, technology<br />

assessment is reviewed by the Quality Interagency<br />

Coordination Task Force based in Washington, DC.<br />

Step 3. Critical Appraisal<br />

When reviewing an individual research study or conducting<br />

a meta-analysis, one must assess the work for<br />

relevance and methodologic rigor. This is a critical step<br />

for developing epidemiologic tools to assess the validity<br />

and the quality of the evidence found in the literature.<br />

There are different levels of evidence and grades for<br />

recommendation. The medical literature may be classified<br />

according to its quality level ranging from type (1), the<br />

highest quality, to type (5) the lowest. Type (1) evidence<br />

is from a systematic review, which includes at least one<br />

randomized controlled trial and a summary of all included<br />

studies. Examples of these studies include those published<br />

by the Cochrane Collaboration, the National Health Service<br />

Centre for Reviews and Dissemination, and the<br />

Agency for Healthcare Research and Quality. The evidence<br />

from such a review requires careful appraisal; if<br />

well done, such evidence is powerful. Type (2) evidence<br />

is from a properly designed randomized controlled trial of<br />

appropriate size. Type (3) evidence is from a well-designed<br />

intervention study without randomization. <strong>Evidence</strong><br />

in this category will only be included if no type (1)<br />

or (2) evidence is available. A common research design is<br />

the before-and-after study. Type (4) evidence is supplied<br />

from a well-designed nonexperimental study (eg, cohort,<br />

case-control or cross-sectional study and any study using<br />

purely qualitative methods). Studies in this category will<br />

only be included if no type (1), (2), or (3) evidence is<br />

available. Economic analyses (cost-effectiveness studies)<br />

are also classified as type (4) evidence. Type (5) evidence<br />

consists of opinions of respected authorities based on<br />

clinical evidence, descriptive studies, or reports of expert<br />

consensus committees.<br />

Step 4. Develop Solutions<br />

Research results, even those that are carefully reviewed,<br />

should not be used to determine patient treatment.<br />

Instead, the practitioner should combine the information<br />

gathered from literature reviews with his or her<br />

clinical expertise and available external evidence. In most<br />

cases, this evidence will consist of the patient’s history<br />

and physical examination and laboratory test results. In<br />

this way, the best diagnostic and therapeutic options<br />

available can be matched to a specific patient’s condition.<br />

Table 2<br />

Trends in Meta-analysis <strong>Medicine</strong> From 1995 to 2002 Using<br />

MEDLINE Search with Subject Heading Words “Metaanalysis”<br />

Year Number of Publications Relative Frequency (%)<br />

1995 274 8.6<br />

1996 261 8.2<br />

1997 331 10.4<br />

1998 350 11.0<br />

1999 397 12.5<br />

2000 491 15.4<br />

2001 544 17.1<br />

2002 534 16.8<br />

Total 3182 100.0<br />

META-ANALYSIS<br />

Definition and Trends<br />

Meta-analysis is a quantitative method for combining<br />

the results of independent studies, usually drawn from<br />

published literature, and for synthesizing summaries and<br />

conclusions, which may be used to evaluate therapeutic<br />

effectiveness and plan new studies (5,6). It has increasingly<br />

been used for evaluating and comparing diagnostic<br />

performances, for example, of imaging modalities (7–9),<br />

biopsy techniques (10), and vascular interventions (11).<br />

The number of papers published on meta-analyses has<br />

increased steadily in the past 10 years. See the trends of<br />

conducting meta-analysis between 1995 and 2002 in the<br />

results of a MEDLINE search using the subject heading<br />

of “meta-analysis” (Table 2).<br />

Advantages<br />

For the purpose of critically evaluating a clinical hypothesis<br />

based on published clinical trials, meta-analysis<br />

is an efficient tool for summarizing the results in the literature<br />

numerically. Meta-analysis allows for an objective<br />

appraisal of the evidence, which may lead to resolution of<br />

uncertainty and disagreement. It can reduce the probability<br />

of false-negative results and thus prevent undue delays<br />

in the introduction of effective treatments into clinical<br />

practice. A priori hypotheses regarding treatment effects<br />

in subgroups of patients may be tested. It may also explore<br />

and sometimes explain the heterogeneity between<br />

study results. Finally, the analysis may help guide the<br />

design of future research. Specifically, the sample size<br />

needed in future studies may be calculated more accurately.<br />

Classic textbooks on meta-analysis have been writ-<br />

129


ZOU ET AL Academic Radiology, Vol 11, No 2, February 2004<br />

ten by several authors (12–15). In the late 1990s, the British<br />

Journal of <strong>Medicine</strong> published a series of articles on<br />

this topic (17–23).<br />

Tools<br />

There are several epidemiologic and statistical tools<br />

required to scientifically synthesize and assemble literature<br />

data in a meta-analysis: (1) a carefully considered<br />

and detailed protocol should be written before beginning<br />

the project; (2) an a priori definition of eligibility criteria<br />

should be included, with a comprehensive search for such<br />

studies as a central part of the work; (3) the results<br />

should be graphed on a common scale to allow a visual<br />

examination of the heterogeneity between studies; (4) an<br />

appropriate statistical method should be chosen for combining<br />

data; and (5) a thorough “sensitivity” analysis<br />

should be performed to assess the robustness of combined<br />

estimates using different assumptions and inclusion criteria.<br />

In Table 3, we illustrate these five tools on a wellconducted<br />

meta-analysis by Oei et al. (9). The authors<br />

evaluated the diagnostic performance of magnetic resonance<br />

imaging of the menisci and cruciate ligaments of<br />

the knee and assessed the effect of study design characteristics<br />

and magnetic field strength on diagnostic performance.<br />

<strong>Based</strong> on 29 of the 120 retrieved articles, the authors<br />

found that the performance of magnetic resonance<br />

imaging differed according to lesion types and was influenced<br />

by study designs. In addition, higher magnetic field<br />

strength moderately improved diagnostic accuracy, with a<br />

significant effect on the identification of anterior cruciate<br />

ligament tears.<br />

Sources of Biases<br />

We have already defined the classification system of<br />

quality of the literature under EBM. However, there are<br />

several biases that may lead to an erroneous conclusion.<br />

The most common types of bias include: (1) publication<br />

bias: significant results are more likely to get published;<br />

(2) language and citation bias: among published studies,<br />

those with significant results are more likely to get published<br />

in English, to be cited, and to be published repeatedly;<br />

(3) database bias: in less developed countries, studies<br />

with significant results may be more likely to get published<br />

in a journal indexed in a literature database; and<br />

(4) inclusion bias: criteria for including studies in a metaanalysis<br />

may be influenced by knowledge of the results of<br />

the set of potential studies. To minimize these possible<br />

biases, one must search the world literature thoroughly<br />

Table 3<br />

A Step-by-Step Illustration of a Toolbox for Meta-analysis on<br />

a Published Study on MRI of the Menisci and Cruciate<br />

Ligaments<br />

Step Tools Methods Applied<br />

1. Detailed<br />

protocol<br />

2. Eligibility<br />

criteria<br />

3. Graphical<br />

display<br />

4. Statistical<br />

methods<br />

5. Sensitivity<br />

analysis<br />

Search engine: MEDLINE<br />

Date: January 1991–December 2000<br />

Purpose: Diagnostic performance of MRI<br />

of knee lesions<br />

Terms: Magnetic resonance imaging, knee,<br />

meniscus, cruciate ligament, arthroscopy<br />

Extractors: Two independent readers, with<br />

third reader assessing discrepancies<br />

Study characteristics: Publication year,<br />

country, setting, patient characteristics,<br />

aspects of study design, verification<br />

bias, characteristics of MRI<br />

Likelihood for inclusion: Yes, possible, no<br />

(1) Inclusion criteria:<br />

Language: English<br />

Diagnosis: MRI of lesions of medial or<br />

lateral meniscus, ACL, or PCL<br />

Sample size: At least 30 subjects<br />

Gold standard: Arthroscopy<br />

Measurement: Magnetic field strength<br />

Threshold: Positive criteria for MRI<br />

Outcome data: Absolute numbers of TP,<br />

FN, TN, and FP<br />

(2) Exclusion:<br />

Patient population: Consists of infants or<br />

adolescents<br />

Study objective: MRI for postoperative<br />

evaluation<br />

Study design: Case-control<br />

Ligaments: Only the medial and lateral<br />

meniscus combined<br />

Measurement: Various magnetic field<br />

strengths<br />

Outcome data: Only the diagnostic value<br />

of specific features and indirect signs of<br />

knee lesions at MRI<br />

Funnel plot of log odds ratio<br />

Summary ROC plot<br />

Pooled weighted analysis of sensitivity and<br />

specificity<br />

Random effects model<br />

Summary ROC analysis per lesion and for<br />

all lesions<br />

Delete-one Jackknife method<br />

Note.—MRI magnetic resonance imaging; ACL anterior<br />

cruciate ligament; PCL posterior cruciate ligament; TP true<br />

positive; FN false negative; TN true negative; FP false<br />

positive; ROC receiver operating characteristic.<br />

130


Academic Radiology, Vol 11, No 2, February 2004<br />

WHAT IS EVIDENCE-BASED MEDICINE?<br />

Table 4<br />

Summary Measures Commonly Used for Conducting Meta-analysis in Radiology<br />

Summary Measure<br />

Sensitivity (true positive rate)<br />

Specificity (true negative rate)<br />

Positive predictive value<br />

Negative predictive value<br />

Likelihood ratio<br />

Odds ratio<br />

Relative risk<br />

Receiver operating curve<br />

Definition<br />

The proportion of subjects with disease who have a positive test.<br />

The proportion of subjects without disease who have a negative test<br />

The proportion of test positive subjects who truly have disease.<br />

The proportion of test negative subjects who truly do not have disease.<br />

The probability that a subject with disease would have a particular test result divided by the probability<br />

that a subject without the disease would have that result.<br />

The probability of the disease occurring divided by the probability that it doesn’t occur.<br />

The probability of the disease in the risk group divided by the probability of the disease in the control<br />

group.<br />

A plot of (1-specificity, sensitivity) at all possible decision threshold.<br />

Table 5<br />

Absolute Diagnostic Rates in the Computed Tomography of Metastasis in Lung Cancer(35)<br />

Study<br />

Sample<br />

Size (n)<br />

True<br />

Positive<br />

(TP)<br />

False<br />

Negative<br />

(FN)<br />

False<br />

Positive<br />

(FP)<br />

True<br />

Negative<br />

(TN) Sensitivity Specificity<br />

1 50 11 7 6 26 0.611 0.813<br />

2* 35 2 5 15 13 0.287 0.464<br />

3 51 15 2 2 32 0.833 0.941<br />

4 22 4 1 4 13 0.800 0.765<br />

5 50 22 21 1 6 0.512 0.857<br />

6 42 17 1 9 15 0.944 0.625<br />

7 94 29 10 1 54 0.744 0.982<br />

8 41 8 6 4 23 0.571 0.852<br />

9 50 7 6 12 25 0.538 0.676<br />

10 49 20 1 10 18 0.952 0.643<br />

11 48 19 1 9 19 0.950 0.679<br />

12 97 18 6 8 65 0.750 0.890<br />

13 41 18 1 9 13 0.947 0.591<br />

14 75 17 3 6 49 0.850 0.891<br />

Note—*Data from Study 2 were not included in the analysis because of inhomogeneity. Sensitivity TP/(TP FN) and Specificity <br />

TN/(FP TN)<br />

and use eligibility criteria stringently (24–26). A tutorial<br />

article addressing the statistical methods for meta-analysis<br />

including reduction of bias was published in 1999 by<br />

Normand (27).<br />

Diagnostic Imaging: A Receiver Operating<br />

Characteristic Curve<br />

There are several summary outcomes derived from<br />

meta-analyses useful for imaging research (28–30). These<br />

include sensitivity, specificity, predictive value, likelihood<br />

ratio, odds ratio, relative risk, and summary receiver operating<br />

characteristic (SROC) curve (Table 4). SROC methods<br />

are designed to show the accuracy of a specific test at<br />

predetermined sensitivity and specificity levels. There are<br />

several methods to derive such a curve. Kardaun and<br />

Kardaun (31) used a bivariate normal maximum-likelihood<br />

method. Littenberg et al. (32) employed a logit difference–sum<br />

regression model, in which the logit-transformed<br />

true-positive fraction and false-positive fraction<br />

have a linear relationship; logit(p) ln{p/(1p)}. Recently,<br />

the logit difference–sum method was validated via<br />

statistical simulations (33). A more complicated approach<br />

using a latent-scale logistic regression analysis model was<br />

developed by Rutter and Gatsonis (34).<br />

As a simple example for derivation of the summary<br />

ROC curve, Table 5 provides the subset data from 14<br />

131


ZOU ET AL Academic Radiology, Vol 11, No 2, February 2004<br />

Figure 1. Summary Receiver Operating Curves of Diagnostic Rates in the Computed<br />

Tomography of Metastasis in Lung Cancer by Two Estimation Methods.<br />

studies found by Inouye and Sox (35) and analyzed by<br />

both Kardaun and Kardaun and by Litternberg et al. The<br />

intention of this meta-analysis was to evaluate the diagnostic<br />

accuracy of CT scans for detecting metastases in<br />

patients with non–small-cell lung cancer. Summary ROC<br />

curves were constructed based on 13 studies. Data from<br />

study 2 were omitted because the sensitivity and specificity<br />

were less than 0.5, which was not homogeneous with<br />

remaining data. The two analysis models yielded the summary<br />

ROC curves, both displayed in Figure 1. The logit<br />

difference–sum model gave the estimated regression equation<br />

logit(TP) 3.26 1.12 logit(FP), whereas the<br />

bivariate normal maximum-likelihood model gave the<br />

estimated equation logit(TP) 3.71 1.64 logit(FP).<br />

The large area under the ROC curves showed that CT<br />

was accurate in diagnosis of metastatic lung nodes.<br />

SUMMARY<br />

In this brief review article, we present the concepts<br />

and steps for EBM and meta-analysis, with a focus on<br />

evidence-based radiology. Careful scientific methodology<br />

is called for to minimize biases and to systematically synthesize<br />

medical literature. The application of EBM principles<br />

to diagnostic imaging can facilitate the interpretation<br />

of imaging studies and create a well-conducted radiologic<br />

evaluation.<br />

REFERENCES<br />

1. The <strong>Evidence</strong>-<strong>Based</strong> Radiology Working Group. <strong>Evidence</strong>-based<br />

radiology: a new approach to the practice of radiology. Radiology<br />

2001; 220:566–575.<br />

2. Eisenberg JM. Then lesions for evidence-based technology assessment.<br />

JAMA 1999; 282:1865–1869.<br />

3. Hoffrage U, Lindsey S, Hertwig R, et al. <strong>Medicine</strong> communicating statistical<br />

information. Science 2000; 290:2261–2262.<br />

4. Sackett DL, Straus SE, Richardson S, et al: <strong>Evidence</strong>-based medicinehow<br />

to practice and teach EBM. 2nd ed. Edinburgh, Scotland:<br />

Churchill Livingstone, 2000.<br />

5. Jaeschke R, Guyatt G, Sackett DLfor the <strong>Evidence</strong>-<strong>Based</strong> <strong>Medicine</strong><br />

Working Group. Users’ guides to the medical literature, III. How to<br />

use an article about a diagnostic test. B. <strong>What</strong> are the results and<br />

will they help me in caring for my patients? JAMA 1994; 271:703–<br />

707.<br />

6. Langlotz CP, Sonnad SS. Meta-analysis of diagnostic procedures: A<br />

brief overview. Academic Radiology 1998; 5(Suppl. 2):S269–S273.<br />

132


Academic Radiology, Vol 11, No 2, February 2004<br />

WHAT IS EVIDENCE-BASED MEDICINE?<br />

7. Visser K, Hunink MG. Peripheral arterial disease: A gadolinium-enhanced<br />

MR angiography versus color-guided duplex US—meta-analysis.<br />

Radiology 2000; 216:67–77.<br />

8. Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from<br />

cancers of the gastrointestinal tract by using noninvasive imaging<br />

methods (US, CT, MR imaging, PET): A meta-analysis. Radiology<br />

2002; 224:748–756.<br />

9. Oei EHG, Nikken JJ, Verstignen ACM, et al. MR imaging of the menisci<br />

and cruciate ligaments: A systematic review. Radiology 2003;<br />

226:837–848.<br />

10. Samson DJ, Flamm CR, Pisano ED, et al. Should FDG PET be used to<br />

decide whether a patient with an abnormal mammogram or breast<br />

finding at physical examination should undergo biopsy? Acad Radiol<br />

2002; 9:773–783.<br />

11. MacEneaney PM, Malone DE. Applying “evidence-based medicine”<br />

theory to interventional radiology. II. A spreadsheet for swift assessment<br />

of procedural benefit and harm. Clin Radiol 2000; 55:938–945.<br />

12. Hedges LV, Olkin I. Statistical methods for meta-analysis. New York:<br />

Academic Press, 1985.<br />

13. Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the confidence<br />

profile method. The statistical synthesis of evidence. Boston: Academic<br />

Press, 1992.<br />

14. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness<br />

analysis. Methods for quantitative synthesis in medicine. New York:<br />

Oxford University Press, 1994.<br />

15. Cooper H, Hedges LV. The handbook of research synthesis. New<br />

York: Russell Sage Foundation, 1994.<br />

16. Rosenberg W, Donald A. <strong>Evidence</strong> based medicine: An approach to<br />

clinical problem-solving. BMJ 1995; 310:1122–1126.<br />

17. Sackett DL, Rosenberg WM, Gray JA, et al. <strong>Evidence</strong> based medicine:<br />

<strong>What</strong> it is and what it isn’t. BMJ 1996; 312:71–72.<br />

18. Egger M, Smith DG. Meta-analysis: Potential and promise. BMJ 1997;<br />

315:1371–1374.<br />

19. Egger M, Davey Smith G. Meta-analysis: Principles and procedure.<br />

BMJ 1997; 315:1533–1537.<br />

20. Smith DG, Egger M, Phillips AN. Meta-analysis: Beyond the grand<br />

mean. BMJ 1997; 315:1610–1614.<br />

21. Egger M, Smith DG. Meta-analysis: Bias in location and selection<br />

studies. BMJ 1998; 316:61–66.<br />

22. Egger M, Schneider M, Smith DG. Spurious precision? Meta-analysis<br />

of observational studies. BMJ 1998; 316:140–144.<br />

23. Smith DG, Egger M. Meta-analysis: Unresolved issues and future developments.<br />

BMJ 1998; 316:221–225.<br />

24. Lyengar S, Greenhouse J. Selection models and the file-drawer problem.<br />

Stat Sci 1988; 3:109–135.<br />

25. Dear KB, Begg CB. An approach for assessing publication bias prior<br />

to performing a meta-analysis. Stat Sci 1992; 7:237–245.<br />

26. Hedges LV. Modeling publication selection effects in meta-analysis.<br />

Stat Sci 1992; 7:246–255.<br />

27. Normand S-LT. Meta-analysis: Formulating, evaluating, combining,<br />

and reporting. Stat Med 1999; 18:321–359.<br />

28. Rockette HE, Gur D, Campbell WL, et al. Use of meta-analysis in the<br />

evaluation of imaging systems. Acad Radiol 1994; 1:63–69.<br />

29. Walter SD, Jadad AR. Meta-analysis of screening data: A survey of<br />

the literature. Stat Med 1999; 18:3409–3424.<br />

30. Irwig L, Macaskill P, Glasziou P, et al. Meta-analytic methods for diagnostic<br />

test accuracy. J Clin Epidemiol 1995; 48:119–130.<br />

31. Kardaun JWPF, Kardaun OJWF. Comparative diagnostic performance<br />

of three radiological procedures for detection of lumbar disk herniation.<br />

Meth Info Med 1990; 29:12–22.<br />

32. Moses LE, Shapiro D, Littenberg B. Combining independent studies of<br />

a diagnostic test into a summary ROC curve: Data-analytic approaches<br />

and some additional considerations. Stat Med 1993;<br />

12:1293–1316.<br />

33. Mitchell MD. Validation of the summary ROC for diagnostic test metaanalysis:<br />

A monte-carlo simulation. Acad Radiol 2003; 10:25–31.<br />

34. Rutter CM, Gatsonis CA. Regression methods for meta-analysis of<br />

diagnostic test data. Acad Radiol 1995; 2(Suppl. 1):S48–S56.<br />

35. Inouye SK, Sox HC. Standard and computed tomography in the evaluation<br />

of neoplasms of the chest. Ann Int Med 1986; 105:906–924.<br />

133

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!